Gynecology Enhancement: Maribee T. Espiritu, RN, MD
Gynecology Enhancement: Maribee T. Espiritu, RN, MD
Gynecology Enhancement: Maribee T. Espiritu, RN, MD
2
3
Spontaneous abortion
4
• Sixty percent of spontaneous abortions in
the first trimester are a result of chromosomal
abnormalities.
5
• Top etiologies of spontaneous abortion:
1) Chromosomal abnormalities
2) Unknown
3) Infection
4) Anatomic defects
5) Endocrine factors
6
ETIOLOGIES
• Chromosomal Abnormalities
– Majority of abnormal karyotypes are numeric
abnormalities as a result of errors during
gametogenesis, fertilization, or the first division of
the fertilized ovum.
7
• Infectious Agents
– Infectious agents in cervix, uterine cavity, or
seminal fluid can cause abortions.
8
• These infections may be asymptomatic:
– Toxoplasma gondii
– Herpes simplex
– Ureaplasma urealyticum
– Mycoplasma hominis
9
Uterine Abnormalities
10
Endocrine Abnormalities
• Progesterone deficiency
• Polycystic ovarian syndrome (POS)—
hypersecretion of luteinizing hormone (LH)
• Diabetes—uncontrolled
11
Immunologic Factors
• Lupus anticoagulant
• Anticardiolipin antibody (antiphospholipid
syndrome)
Environmental Factors
• Tobacco––≥ 14 cigarettes/day increases
abortion rates
• Alcohol
• Irradiation
• Environmental toxin exposure
12
THREATENED ABORTION
13
• DIAGNOSIS
– Speculum exam reveals blood coming from a
closed cervical os, without amniotic fluid or
POC in the endocervical canal.
14
• MANAGEMENT
– Bed rest with sedation and without intercourse
– Twenty to 50% of threatened abortions lead
to loss of pregnancy.
15
INEVITABLE ABORTION
16
• DIAGNOSIS
– Speculum exam reveals blood coming from an
open cervical os
– Menstrual-like cramps typically occur
17
• MANAGEMENT
– Surgical evacuation of the uterus
– Rh typing—D immunoglobulin (RhoGAM) is
administered to Rh negative, unsensitized patients
to prevent isoimmunization.
18
• Inevitable abortion is different from
threatened
abortion because it has cervical dilation.
19
INCOMPLETE ABORTION
• DIAGNOSIS
– Cramping and heavy bleeding
– Enlarged, boggy uterus
– Dilated internal os with POC present in the
endocervical canal or vagina
20
MANAGEMENT
• Stabilization
– IV fluids and oxytocin if heavy bleeding is present
• Blood typing and crossmatching for possible
transfusion
• Rh typing
• POC are removed from the endocervical
canal and uterus with ring forceps.
• Suction dilation and curettage (D&C)
21
COMPLETE ABORTION
• DIAGNOSIS
– Uterus is well contracted.
– Cervical os may be closed.
– Pain has ceased.
22
• MANAGEMENT
– Examine all POC for completeness and
characteristics.
– Between 8 and 14 weeks
• curettage is necessary
• large possibility that the abortion was incomplete.
– Observe patient for further bleeding and fever.
23
MISSED ABORTION
• DIAGNOSIS
– pregnant uterus fails to grow, and symptoms of
pregnancy have disappeared.
– Intermittent vaginal bleeding/spotting/brown
discharge and a firm, closed cervix
– Decline in quantitative beta-hCG
– US confirms lack of fetal heartbeat.
24
• MANAGEMENT
– Although most women will spontaneously deliver a
dead fetus within 2 weeks
– psychological stress imposed by carrying a dead
fetus
– dangers of coagulation defects favor the practice
of labor induction and early delivery
25
• Check fibrinogen level, partial thromboplastin
time (PTT), antibody screen, and ABO blood
type.
• Evacuate the uterus (suction D&C in first
trimester)
• induce labor with IV oxytocin and cervical
dilators or prostaglandin E2 suppositories.
• Administer RhoGAM to Rh-negative,
unsensitized patients
26
PRETERM LABOR
27
Risk Factors
• Multiple gestation
• History of previous labor &/or delivery
• Abdominal surgery during current pregnancy
• Uterine anomaly
• History of cone biopsy
• History of abortion
– >2 1st trimester abortions or
– >1 2nd trimester abortion
• Fetal/maternal malformation
28
• Maternal age
• Poor nutritional status
• Poor, irregular pre-natal care
• Smoking
• Drug use
29
Nursing Management
• Provide accurate information on the
status of the fetus and labor
• Encourage visits from family
especially other children and
friends
• Plan for a daily rest period
30
Medical Management
• Goal is to prevent the delivery of a preterm infant
– Bed rest in a left lateral position
– Hydration with IVF
– Tocolytic therapy (Ritodrine, Isoxuprine, Terbutaline)
– Side effects
• ↑ PR and Blood volume
• ↓BP
31
Medical Management
• Laboratory exam done before giving the meds
– CBC
– Electrolytes
– Glucose
– BUN, Crea
– PT, PTT
32
PREMATURE RUPTURE OF
MEMBRANES
33
• spontaneous rupture of fetal membranes
before the onset of labor
• can occur at term (PROM) or preterm
(PPROM).
34
• multiple pregnancy
• Chorioamnionitis
• breech presentation
• fetal distress in labor
35
Etiology
36
Risks
37
Complications:
38
if preterm PROM
• Prematurity
• Oligohydramnios
– occurs at < 24 weeks
– risk of oligohydramnios
– may cause pulmonary hypoplasia
– Survival at this age is low
39
Diagnosis of Rupture of Membranes
(ROM)
• A digital exam should not be performed, as it
increases the risk of infection:
• Sterile speculum examination:
– Visualize extent of cervical effacement and dilation
– exclude prolapsed cord or protruding fetal
extremity.
40
• Pool test
– Identify fluid coming from the cervix or pooled in
the posterior fornix of the vagina → supports
diagnosis of PROM.
• Nitrazine test
– Put fluid on nitrazine paper, which turns blue if
fluid is alkaline
– Alkaline pH indicates fluid is amniotic.
41
• Ferning test
– A swab from the posterior fornix is smeared on a
slide, allowed to dry, and examined under a
microscope for “ferning”
– + for amniotic fluid.
42
Management of All PROM Patients
43
Management of All PROM Patients
44
• begin ampicillin and/or erythromycin
prophylaxis.
• Amniotic fluid assessment of L:S ratio
– for lung maturity
• Perform ultrasound to assess
– gestational age
– position of baby
– Level of fluid.
45
• If < 34 weeks
– give steroids to decrease incidence of RDS
• Expectant management
46
Terms:
• ROM:
– Rupture of membranes
• PROM:
– Premature rupture of membranes (ROM before the
onset of labor)
• PPROM:
– Preterm (< 37 weeks) premature rupture of
membranes
• Prolonged rupture of membranes:
– Rupture of membranes that lasts for 18 hrs
Management
• Tocolytic therapy
– used until fetal lungs have
– 2 doses of Betamethasone given
– delivery is delayed for at least 24hrs
– Evaluate amount and odor of amniotic fluid
– Do not perform internal examination
48
• Place patient on disposal pad
– to collect leaking fluid
– Change pads every 2 hrs or more
frequently as needed
– fetal heart rate q2
– maternal temperature q2
– PR, RR, BP, and uterine tenderness
every 4 hrs
49
PREGNANCY INDUCED HYPERTENSION
– PIH
– Toxemia of pregnancy
50
PREGNANCY-INDUCED HYPERTENSION
(PIH)
• Subsets of PIH
1. Preeclampsia
- Renal involvement leads to proteinuria
- Hypertension
- edema
2. Eclampsia
CNS involvement leads to seizures.
PREGNANCY INDUCED HYPERTENSION
• Actual cause is UK
• Theory :
– exposure to chorionic villi for the first
time
– large amounts of chorionic villi
53
CONTRIBUTING FACTORS
• nulligravida
• adolescents and women over 35
• Multigravida with multiple gestations
• Multigravida with history of chronic
hypertension, DM, renal disease
54
CLINICAL MANIFESTATIONS
• Hypertension
– BP of 140/90 mmHg or greater
• Proteinuria
– 300mg or more in 24 hr
• Edema
– non-dependent
– present after 8-12 hrs of bed rest
• Weight gain
– more than 2 lb in 1 week or
– 6 lbs in 1 month
55
MANAGEMENT
56
MANAGEMENT
57
• Evaluate for signs of abruptio placenta
• Urine output at least 300ml or more/ voiding
• Position patient to left lateral position
• Magnesium sulfate
– to prevent and treat convulsions
– decreases the neuromuscular irritability
– depresses the CNS
58
• MgSO4 is administered IV with a
LD of 3-4 gm
– followed by hourly doses of 1-4 gm
– irritating to the veins
– IM administration
• 5 gm in each hip every 4 hrs
• z-tract
59
• Urine output monitored
– to avoid toxicity
• Deep Tendon Reflexes (DTR)
should be evaluated
60
• Magnesium level should be 4-7.5 mEq/L
• Calcium gluconate- antidote
• Hydralazine (Apresoline)
– relaxes the arterioles and stimulates cardiac
output
– Drug of choice for hypertension
61
ANTIHYPERTENSIVE AGENTS USED IN
PREGNANCY
• Short-Term Control
– Hydralazine: IV or PO
– vasodilator
– SE: headache, palpitations
– Labetalol: IV or PO
– nonselective beta-1 and alpha-1 blocker
– SE: Headache and tremor
ECLAMPSIA
Management
• Long-Term Control
– Methyldopa:
• sympatholytic
• SE: fluid retention
– Nifedipine:
• calcium channel blocker
– Atenolol:
• PO
• selective beta-1 blocker
• Diazepam may be used if
convulsions occur
• Severe complication of PIH is the
HELLP syndrome
– Hemolysis
– Elevated Liver enzymes
– Low Platelet
64
RH INCOMPATIBILITY AND
PREGNANCY
65
What Is Rh?
66
• Hemolytic Disease of the Newborn (HDN)
• Erythroblastosis Fetalis
67
The Problem with Rh Sensitization
68
Sensitization
• Amniocentesis
• Miscarriage/threatened abortion
• Vaginal bleeding
• Placental abruption/previa
• Delivery
• Abdominal trauma
• Cesarean section
• External version
69
Screening
70
Screening
• RhoGAM
– is RhIgG
– IgG that will attach to the Rh antigen
– prevent immune response by the mother
71
Maternal Antibodies causes:
72
73
74
Managing the Unsensitized Rh−
75
Management of the Sensitized Rh−
Patient
• Perform antibody screen at 0, 12 to 20
weeks.
• Check the antibody titer.
– If titer remains stable at < 1:16, the likelihood of
HDN is low.
– If the titer is > 1:16 and/or rising, the likelihood of
HDN is high.
76
• Amniocentesis begins at 16 to 20 weeks’ GA
• Fetal cells are analyzed for Rh status.
77
Cardiac disease
78
NEW YORK HEART ASSOCIATION FUNCTIONAL
CLASSIFICATION OF CARDIAC DISEASE
12/08/21 79
NEW YORK HEART ASSOCIATION FUNCTIONAL
CLASSIFICATION OF CARDIAC DISEASE
The criteria committee of the New York Heart Association, Nomenclature and criteria for diagnosis of diseases of heart and
great vessels, Edi 8, New York Association,1979.
12/08/21 80
– most women in class 1 and 2
• able to handle the physiologic demands of pregnancy
– cardiac status is carefully monitored throughout pregnancy
– monitor for signs of cardiac decompensation
• crackles at lung base
• cough
• hemoptysis
• dyspnea on exertion
• cyanosis
• labored respiration
• increased pulse
• edema of face, ankles and hands
81
Management
– Class 1 and 2
• 10 hrs of rest at night
– 30 mins after every meal
• Weight gain limited to 24 lb
• Diet: high in iron, low sodium
• No heavy work permitted
• Medications are used as needed
– to control symptoms
• Relief of pain and anxiety
– primary goal during labor
82
– Class 1 and 2
• Vaginal delivery
– delivery method of choice
• During the postpartum
– VS are closely monitored for signs of CHF
• Contraception is stressed
83
– Class 3
• 1st trimester
– counseled regarding a therapeutic abortion
• if the pregnancy continues
– Treatment with class 1 and 2 +
– hospitalization with strict bed rest for most of the
duration of the pregnancy
• vaginal delivery is preferred
• VS closely monitored for signs of CHF
84
– Class 4
• same care with the preceeding class
• woman has CHF for most of the
pregnancy and is treated as such
• delivery and postpartum periods
– especially critical
85
• Semi-fowler’s position
• Left side lying position
• evaluate fetal growth weekly
• measure the fundal height
• evaluate FHR daily
• evaluate weight weekly
86
GESTATIONAL DIABETES
87
DIABETES MELLITUS
• Gestational DM
• Body unable to produce enough insulin
to meet the needs for glucose
metabolism
• pregnancy is diabetogenic state
88
• Pregestational diabetes—patient had DM
before pregnancy
89
Screening
90
91
• 3-Hour glucose tolerance test
– if glucose challenge test is > 140 and < 200
– Draw fasting glucose level
• norma l(n) < 95
– Give 100-g glucose load.
– Draw glucose levels at
• 1 hour (n < 180)
• at 2 hours (n < 155)
• at 3 hours (n < 140)
– Positive for gestational diabetes if 2/4 high values
92
Risk Factors
93
Effects of Gestational Diabetes
• Maternal Effects
– Four times increased risk of preeclampsia
– Increased risk of bacterial infections
– Higher rate of C-section
– Increased risk of polyhydramnios
– Increased risk of birth injury
94
• Fetal Effects
– Increased risk of perinatal death
– Three times increased risk of fetal anomalies
(renal, cardiac, and CNS)
– Two to three times increased risk of preterm
delivery
– Fetal macrosomia increases risk of birth injury.
– Metabolic derangements (hypoglycemia,
hypocalcemia)
95
Management
96
Starting at 32 to 34 weeks:
• Fetal monitoring:
– Ultrasonography at 16 to 20 weeks’ GA
– For fetal growth, GA, amniotic fluid volume
• Nonstress test and amniotic fluid index
testing weekly to biweekly
• Biophysical profile
97
Starting at 32 to 34 weeks:
98
• If fetal weight is > 4,500 g
– elective cesarean section should be considered to
avoid shoulder dystocia
– Unless there is an obstetric complication, induction
of labor and vaginal delivery are done.
99
• Onset during pregnancy
– second or third trimester
– Due to hormones secreted by the placenta that
inhibit the action of insulin
100
DIABETES MELLITUS
• Clinical Manifestations
– 3 p’s and weight loss
– blood glucose level >140 mg/dl at 24-28 wks
– glucosuria
– urine positive for ketones
– history of monilial infection
– GCT with 50gm glucose
– re-evaluating after 1 hr (24th-28th AOG)
101
DIABETES MELLITUS
• Management
– aim is to control the glucose level
• maintain a state of euglycemia
– diet, exercise and insulin
– insulin administration in the morning
102
DIABETES MELLITUS
103
ECTOPIC PREGNANCY
(EXTRAUTERINE PREGNANCY)
• implantation of the blastocyst anywhere other
than the endometrial lining of the uterine
cavity
• It is a medical emergency
104
• Ectopic pregnancy is the leading cause of
pregnancy-related death during T1
105
106
Etiology/Risk Factors
107
• Assisted reproduction:
– Ovulation-inducing drugs
– In vitro fertilization
108
Symptoms and Diagnosis
• Amenorrhea
• irregular vaginal bleeding
• Adnexal tenderness or mass
• US evidence of an adnexal mass without
intrauterine gestation
• An adnexal gestational sac with a fetal pole
and cardiac activity
109
• Less-than-normal increase in hCG
• A serum progesterone level lower than
normal for patients with an intrauterine
pregnancy (i.e., < 25 ng/mL)
• Laparoscopy shows an adnexal mass or
abdominal gestation.
110
• Signs of Rupture
– Shock
– Bleeding
– Increased abdominal pain
111
Management
112
• Medical
– Intramuscular methotrexate (prevents DNA
synthesis via its antifolate actions)
– Patient is monitored as an outpatient.
– 67 to 100% effective
113
• If ruptured, always stabilize with IV fluids,
blood replacement
114
115
116
DISSEMINATED INTRAVASCULAR
COAGULATION (DIC)
• or consumptive coagulopathy
• pathological condition associated with
inappropriate activation of the coagulation
and fibrinolytic system.
117
DISSEMINATED INTRAVASCULAR
COAGULATION (DIC)
118
Pathophysiology
119
Diagnosis
• Physical exam
– multiple bleeding points associated with purpura
and petechiae.
• Lab evaluation
– thrombocytopenia
– hypofibrinogenemia
– Elevated prothrombin time
– increased fibrin split products.
120
Management
• Supportive therapy
– to correct/prevent shock, acidosis, and tissue
ischemia
• prompt termination of pregnancy.
121
122
Gestational Trophoblastic Neoplasias
(GTN)
• HYDATIDIFORM MOLE
• Complete Mole
• A placental (trophoblastic) tumor forms when
a maternal ova devoid of DNA
• is “fertilized” by the paternal sperm:
123
• Karyotype:
– Most have karyotype 46XX, resulting from sperm
penetration and subsequent DNA replication.
– Some have 46XY, believed to be due to two
paternal sperms simultaneously penetrating the
ova.
124
Partial Mole
125
Invasive Mole
126
• HISTOLOGY OF HYDATIDIFORM MOLE
– Trophoblastic proliferation
– Hydropic degeneration (swollen villi)
– Lack/scarcity of blood vessels
127
• SIGNS AND SYMPTOMS
– Passage of vesicles (look like grapes)
– Preeclampsia < 20 weeks
– Abnormal painless bleeding in first trimester
128
• DIAGNOSIS
– hCG > 100,000 mIU/mL
– Absence of fetal heartbeat
– Ultrasound- “snowstorm” pattern
– Pathologic specimen—grapelike vesicles
129
• Treatment of Complete or Partial Moles
– Dilation and curettage (D&C)
• to evacuate and terminate pregnancy
– Follow-up with the workup to rule out invasive
mole (malignancy)
– Chest x-ray (CXR) to look for lung mets
– Liver function tests to look for liver mets
130
• Weekly hCG level:
– hCG level should decrease and return to normal
within 2 months
– If the hCG level rises, does not fall, or falls and
then rises again
• molar pregnancy is considered malignant
• metastatic workup and chemotherapy is necessary.
• Contraception should be used during the 1-
year follow-up.
131
• Metastatic Workup
– CXR
– computed tomography (CT) of brain, lung, liver,
kidneys
132
Treatment (For Nonmetastatic Molar
Pregnancies)
• Chemotherapy
– methotrexate or actinomycin-d (as many cycles as
needed until hCG levels return to normal)
or
• Total abdominal hysterectomy +
chemotherapy (fewer cycles needed)
133
134
135
136
137
PELVIC INFLAMMATORY DISEASE
(PID)
• Inflammation of the female upper genital tract
(uterus, tubes, ovaries, ligaments)
• caused by ascending infection from the
vagina and cervix
138
• Common Causative Organisms
– Neisseria gonorrhoeae
– Chlamydia trachomatis
– Escherichia coli, Bacteroides
139
• Diagnosis
– Physical Exam
– Abdominal tenderness
– Adnexal tenderness
– Cervical motion tenderness
140
Lab Results and Other Possible Exam
Signs
• +/− Fever
• Gram-positive staining
• Pelvic abscess
• Elevated white count
• Purulent cervical discharge
141
Laparoscopy
142
Risk Factors
143
Criteria for Hospitalization
• Pregnancy
• Peritonitis
• Gastrointestinal (GI) symptoms
– nausea
– vomiting
• Abscess (tubo-ovarian or pelvic)
• Uncertain diagnosis
144
Treatment
• Inpatient
• Cefotetan + doxycycline
– preferred for chlamydia
• Clindamycin + gentamicin
– preferred for abscess
145
• Outpatient
• Ofloxacin + metronidazole
• Ceftriaxone + doxycycline
– preferred for chlamydia (because of doxycycline)
• Sexual partners are treated also
146
Infections during Pregnancy
Sexually Transmitted
Disease
CHLAMYDIA
149
Clinical Manifestations
• Asymptomatic
• Mucopurulent discharge
• Cervicitis
• Urethritis PID
• Trachoma
– conjunctivitis resulting in eyelash hypercurvature
and eventual blindness from corneal abrasions
• Fitz-Hugh–Curtis syndrome
150
• SEROTYPES L1–L3
– lymphogranuloma venereum.
• Primary lesion
– painless papule on genitals
• Secondary stage
– Lymphadenitis
• Tertiary stage
– rectovaginal fistulas
– rectal strictures
151
Diagnosis
152
Treatment
• Doxycyline or azithromycin/erythromycin
• CREDE’S PROPHYLAXIS
– newborn
153
SYPHILIS
• Treatment : Penicillin
154
Presentation
155
• Secondary syphilis
– generalized rash (often palms and soles)
– condyloma lata
– mucous patches with lymphadenopathy
– fever
– Malaise
– usually appearing 1 to 6 months after primary
chancre
– Spontaneous regression after about 1 month
156
• Tertiary syphilis
– presents years later
– with skin lesions
– bone lesions (gummas)
– cardiovascular lesions (e.g., aortic aneurysms)
– central nervous system (CNS) lesions (e.g., tabes
dorsalis)
157
Diagnosis
158
Treatment
159
HUMAN PAPILLOMAVIRUS (HPV)
160
Presentation
161
Diagnosis
162
Treatment
• Condylomata acuminata
– Cryosurgery
– laser ablation
– trichloroacetic acid
163
CHANCROID
• Presentation
– papule on external genitalia that becomes a
painful ulcer (unlike syphilis, which is painless)
– with a gray base
– Inguinal lymphadenopathy also is possible.
164
Etiology
• Haemophilus ducreyi
• Diagnosis
– Gram stain of ulcer or inguinal node aspirate
showing gram-negative rods
• Treatment
– Ceftriaxone, erythromycin, or azithromycin
165
VAGINITIS
166
Etiology
• Antibiotics
– destabilize the normal balance of flora
• Douche
– raises the pH
• Intercourse
– raises the pH
• Foreign body
– serves as a focus of infection and/or inflammation
167
Diagnostic Characteristics
• Clinical characteristics
• Quality of discharge
• pH
– secretions applied to test strip reveal pH of
discharge.
• “Whiff” test
– combining vaginal secretions with 10% KOH
– Amines released will give a fishy odor
– indicating a positive test.
168
169
170
Bartholin’s Abscess
171
• TREATMENT
– Incision and drainage and marsupialization
• suturing the edges of the incised cyst to prevent
reocclusion
– Or
– Ward catheter
• a catheter with an inflatable tip left in the gland for 10 to
14 days to aid healing
172
GONORRHEA
173
GONORRHEA
174
Presentation
• Asymptomatic
• Dysuria
• Endocervicitis
• Vaginal discharge
• Pelvic inflammatory disease (PID)
175
Diagnosis
176
Treatment
• Ceftriaxone
or
• Ciprofloxacin + doxycycline
or
• Azithromax
• Treat partners.
177
GOOD DAY!!!
178